Physical Therapy Department, Universidade Federal de São Carlos, São Carlos, SP, Brazil; Division of Rheumatology, Allergy and Immunology, Tufts Medical Center, Boston, MA, USA.
Physical Therapy Department, Universidade Federal de São Carlos, São Carlos, SP, Brazil.
Braz J Phys Ther. 2021 Mar-Apr;25(2):135-146. doi: 10.1016/j.bjpt.2020.08.004. Epub 2020 Sep 8.
BACKGROUND: Knee osteoarthritis (OA) is a chronic progressive disease that imparts a substantial socioeconomic burden to society and healthcare systems. The prevalence of knee OA has dramatically risen in recent decades due to consistent increases in life expectancy and obesity worldwide. Patient education, physical exercise, and weight loss (for overweight or obese individuals) constitute the first-line knee OA treatment approach. However, less than 40% of patients with knee OA receive this kind of intervention. There is an unmet need for healthcare professionals treating individuals with knee OA to understand the current recommended treatment strategies to provide effective rehabilitation. OBJECTIVE: To guide physical therapists in their clinical decision making by summarizing the safest and most efficacious treatment options currently available, and by delineating the most traditional outcome measures used in clinical research for knee OA. CONCLUSION: There is a need for healthcare providers to abandon low-quality and ineffective treatments and educate themselves and their patients about the current best evidence-based practices for knee OA.
背景:膝骨关节炎(OA)是一种慢性进行性疾病,给社会和医疗保健系统带来了巨大的社会经济负担。由于全球预期寿命和肥胖率的持续上升,近几十年来,膝骨关节炎的患病率显著上升。患者教育、体育锻炼和减肥(针对超重或肥胖者)是膝骨关节炎的一线治疗方法。然而,只有不到 40%的膝骨关节炎患者接受这种干预。治疗膝骨关节炎患者的医疗保健专业人员需要了解当前推荐的治疗策略,以提供有效的康复,这方面存在着未满足的需求。 目的:通过总结目前可用的最安全和最有效的治疗选择,并描述膝骨关节炎临床研究中最常用的传统疗效指标,为物理治疗师的临床决策提供指导。 结论:医疗保健提供者需要摒弃低质量和无效的治疗方法,并对自己和患者进行有关膝骨关节炎当前最佳循证实践的教育。
Braz J Phys Ther. 2021
Medicine (Baltimore). 2025-8-15
Reumatologia. 2025-4-1
J Exerc Rehabil. 2025-4-30
Osteoarthritis Cartilage. 2020-3
Osteoarthritis Cartilage. 2020-3
Nutrition. 2019-4-10
Clin Exp Rheumatol. 2019-10-15
Interact J Med Res. 2019-9-16